Clinical Trial Update: The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating the safety and efficacy of telitacicept for systemic sclerosis, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Peking University Third Hospital | Conditions: Systemic Sclerosis | Phase 4 | Status: RECRUITING